Menu

Experience

Kay Chandler

    • Neurocrine Partners With Takeda to Address Psychiatric Disorders 


    • Horizon Pharma Buys River Vision for $145 Million and Unspecified Earn-Out 


    • Horizon Pharma Acquisition of Crealta Holdings for $510 Million 


    • Auspex Pharma $3.5 billion sale to Teva Pharma 


    • Horizon Pharma Completes $400 Million Exchangeable Senior Notes Offering 


    • Ambit Biosciences to be Acquired by Daiichi Sankyo for $410 Million 


    • Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility 


    • Horizon Pharma $660 Million Acquisition of Vidara Therapeutics 


    • Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility 


Contact us

Back to top

© 2020 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.